A carregar...
Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis
BACKGROUND: Tumour necrosis factor alpha (TNFα)‐antagonism effectively treats ulcerative colitis (UC). The golimumab clinical programme evaluated subcutaneous (SC) and intravenous (IV) induction, and SC maintenance regimens, in TNFα‐antagonist‐naïve patients with moderate‐to‐severe active UC despite...
Na minha lista:
| Publicado no: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4755132/ https://ncbi.nlm.nih.gov/pubmed/26119226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13291 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|